Straight from what they reported in their most recent quarterly report
Financial Performance
$4.00m in Q3 FY24 unaudited revenue, up 82% QoQ and 297% YoY.
$3.18m in Q3 Personal Testing & Supplements revenue, up 110% QoQ and 420% YoY
$0.82m in Q3 Research Testing revenue, up 20% QoQ and 107% YoY
$4.03m in Q3 FY24 cash receipts, up 217% QoQ and up 224% YoY
$7.28m in YTD FY24 unaudited revenue, up 230% YoY.
Ann: Completion of Autoimmune Program with Ginkgo Bioworks, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 9.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 114482 | 1 |
View Market Depth
| Last trade - 09.59am 30/07/2025 (20 minute delay) ? |
| MAP (ASX) Chart |
Day chart unavailable